| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2011 | US7923458 Method for treating chronic pain |
| 04/12/2011 | US7923457 Quinoline derivatives |
| 04/12/2011 | US7923456 5-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinase |
| 04/12/2011 | US7923455 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 04/12/2011 | US7923454 morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide used for preventing or treating viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers |
| 04/12/2011 | US7923453 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
| 04/12/2011 | US7923451 Antiallergens; asthma; autoimmune disease; pruritius; antiarthritic agents |
| 04/12/2011 | US7923450 Modulators for amyloid beta |
| 04/12/2011 | US7923449 Using 1-(2-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)2,3-dihydro-1H-benzimidazol-2-one |
| 04/12/2011 | US7923448 Purine receptor inhibition as a therapeutic strategy in spinal cord and brain |
| 04/12/2011 | US7923447 Parenteral solutions containing metolazone |
| 04/12/2011 | US7923446 Biaryl sulfonamides and methods for using same |
| 04/12/2011 | US7923444 Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/12/2011 | US7923443 Pharmaceutical composition for the treatment of bone fracture |
| 04/12/2011 | US7923442 Glutathione peroxidase mimetics and uses thereof |
| 04/12/2011 | US7923441 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 04/12/2011 | US7923440 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 04/12/2011 | US7923439 Hydroxamate compositions |
| 04/12/2011 | US7923438 Use of cyclipostin derivatives for the treatment of mycobacterial infectious diseases |
| 04/12/2011 | US7923437 Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same |
| 04/12/2011 | US7923435 Hoodia plant extract with improved flavor |
| 04/12/2011 | US7923434 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/12/2011 | US7923430 Methods for producing modified glycoproteins |
| 04/12/2011 | US7923429 Treatment for CD5+ B cell lymphoma |
| 04/12/2011 | US7923230 Neurodegenerative protein aggregation inhibition methods and compounds |
| 04/12/2011 | US7923044 Composition for high-ORAC value dietary supplement |
| 04/12/2011 | US7923040 Homeopathic formulations useful for treating pain and/or inflammation |
| 04/12/2011 | US7923036 Halogen-containing sanitizing composition |
| 04/12/2011 | US7923035 Humidity-dependent antibacterial powdery composition, process for producing the same, humidity-dependent antibacterial food storing article and method of storing food |
| 04/12/2011 | US7923034 Process for producing microparticles |
| 04/12/2011 | US7923033 comprising protective coatings surrounding the cores containing nutrients, for release into the interstines of ruminants |
| 04/12/2011 | US7923032 polymer compositions of the invention are biodegradable, non-toxic, and provide sustained delivery of therapeutic agents at an area of interest within the central nervous system |
| 04/12/2011 | US7923031 Haemostatic sprays and compositions |
| 04/12/2011 | US7923029 Freeze dried particles; respiratory system disorders |
| 04/12/2011 | US7923028 High dose oral formulation of bisphosphonate and a process for making thereof |
| 04/12/2011 | US7923026 Embedded micellar nanoparticles |
| 04/12/2011 | US7923025 Pharmaceutical composition for oral use with improved absorption |
| 04/12/2011 | US7923018 Vaccine |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7923003 Adhesive for medical applications and means for haemostasis |
| 04/12/2011 | CA2605299C Extended estrogen dosing contraceptive regimen |
| 04/12/2011 | CA2592367C Novel cyclohexane derivatives |
| 04/12/2011 | CA2569216C Pharmaceutical compositions for metabolic insufficiencies |
| 04/12/2011 | CA2554640C Pharmaceutical composition for oral application and method for preparing thereof |
| 04/12/2011 | CA2550023C Treatment of neuropathic pain |
| 04/12/2011 | CA2528496C Acylated amino acid amidyl pyrazoles and related compounds |
| 04/12/2011 | CA2526771C Synthesis of high molecular weight iron-saccharidic complexes |
| 04/12/2011 | CA2522435C Inhibitors of akt activity |
| 04/12/2011 | CA2504730C Cephem compounds |
| 04/12/2011 | CA2502371C Multilayer dosage forms which contain active substances and which comprise a neutral core and an inner and outer coating composed of methacrylate copolymers and methacrylate monomers |
| 04/12/2011 | CA2500118C N-substituted hydromorphones and the use thereof |
| 04/12/2011 | CA2491398C Processes for preparing triethanolamine salts of low molecular weight heparin and their use in topical creams for antithrombotic therapy |
| 04/12/2011 | CA2481480C Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2474875C 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2,-a]pyrimidin-5(1h)-one derivatives |
| 04/12/2011 | CA2473687C Use of polyunsaturated ketones for the treatment of psoriasis |
| 04/12/2011 | CA2471099C .alpha.-(n-sulphonamido)acetamide derivatives as .beta.-amyloid inhibitors |
| 04/12/2011 | CA2462905C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 04/12/2011 | CA2458035C Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/12/2011 | CA2446221C Stable powder inhalation dosage formulation |
| 04/12/2011 | CA2438427C Method for testing effect of angiogenesis inhibitor via integrin expression inhibition |
| 04/12/2011 | CA2438304C Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 04/12/2011 | CA2434060C Preparation of a therapeutic composition |
| 04/12/2011 | CA2430282C Use of substituted 6-dimethylaminomethyl-1-phenylcyclohexane compounds for treating urinary incontinence |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/12/2011 | CA2414241C Polymeric micelle compositions |
| 04/12/2011 | CA2387107C Derivatives of dicarboxylic acid having pharmaceutical properties |
| 04/12/2011 | CA2362925C Methods of treatment of mitochondrial disorders |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA2274670C 15-keto prostaglandins as portal hypertension inhibitors |
| 04/12/2011 | CA2185644C Use of green porphyrins in ocular diagnosis and therapy |
| 04/11/2011 | CA2771651A1 Compositions comprising tramadol and celecoxib in the treatment of pain |
| 04/09/2011 | CA2716914A1 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 04/08/2011 | CA2786834A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 04/08/2011 | CA2717157A1 Nutritional drink |
| 04/07/2011 | WO2011041790A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | WO2011041789A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | WO2011041737A2 Gain-of-function bcl-2 inhibitors |
| 04/07/2011 | WO2011041731A2 Method of inhibiting bcl-2-related survival proteins |
| 04/07/2011 | WO2011041729A2 Compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | WO2011041718A2 Treatment of male-pattern baldness by local induction of the metabolic defect of fabry disease |
| 04/07/2011 | WO2011041710A2 Docosahexaenoic acid gel caps |
| 04/07/2011 | WO2011041697A1 Method of calculating a phosphorus-protein ratio |
| 04/07/2011 | WO2011041694A2 Compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | WO2011041686A1 Human type 1 taste receptor subunit 3 modulators and methods of using same |
| 04/07/2011 | WO2011041655A1 Quinazolin-4-amine derivatives; and methods of use |
| 04/07/2011 | WO2011041648A1 Compositions comprising an anti-inflammatory blend |
| 04/07/2011 | WO2011041640A1 Olopatadine compositions and uses thereof |
| 04/07/2011 | WO2011041639A2 Heteroatom containing substituted fatty acids |
| 04/07/2011 | WO2011041634A1 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | WO2011041632A2 Combination therapies for the treatment of obesity |
| 04/07/2011 | WO2011041599A2 6-methylvitamin d3 analogs and their uses |
| 04/07/2011 | WO2011041596A2 19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring |
| 04/07/2011 | WO2011041590A2 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses |
| 04/07/2011 | WO2011041584A2 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 04/07/2011 | WO2011041579A2 (20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS |
| 04/07/2011 | WO2011041557A1 Method of modulating ire1 activity |
| 04/07/2011 | WO2011041551A1 Therapeutic antiviral peptides |
| 04/07/2011 | WO2011041545A1 Methods of treating aneurysmal dilatation, blood vessel wall weakness and specifically abdominal aortic and thoracic aneurysm using matrix metalloprotease-2 inhibitors |